2.4 - Creatine Kinase Flashcards
1
Q
Creatine kinase reaction
A
creatine phosphate <–> creatine + ATP
- catalysed by creatine kinase
- ADP + H+ –> ATP
2
Q
Where is creatine kinase found?
A
- CK present in all cells but present in particularly high concentrations in metabolically active tissues e.g. skeletal muscle, brain and heart
- following damage or death of such cells CK is released into circulation
- three dimeric isoenzymes of CK are known in humans - there are two different subunits M and B
- MM = skeletal muscle
- MB = cardiac muscle (myocardium, where 15% MB, 85% MM)
- BB = brain muscle
- the three isoenzymes can be separated by electrophoresis on cellulose acetate strips - MM moves furthest towards negative electrode
3
Q
What is a myocardial infarct?
A
- the death of heart muscle cells, due to a lack of oxygen
- lack of oxygen due to blockage of cardiac arteries - process termed atherosclerosis
4
Q
Why do cells need oxygen?
A
- semi-permeable membrane separates inside from outside of cell, actively excluding some things e.g. Na+
- this requires a protein pump in the membrane (ATPases) which use energy in the form of ATP
- ATP is generated via glycolysis, the Krebs cycle and eventually oxidative phosphorylation
- the end point of the process requires atmospheric oxygen, hence if there is less oxygen supplied to a cell there is less ATP, pumps do not function, ion balance is lost and cells die
5
Q
When and why is creatine kinase found in the blood?
A
- cell contents are released when they are dying –> proteins that should be held inside against concentration gradients appear in the serum
- therefore the levels of many proteins including CK (and others e.g. lactate dehydrogenase) in serum can be used as indirect indicators of cell death
6
Q
How might you determine creatine kinase activity?
A
- CK activity in the serum can be detected by a coupled assay leading to the generation of detectable products
- remember NADH (and NADPH) have absorption spectra distinct from NAD+ (and NADP+)
- creatine phosphate + ADP –(CK)–> creatine + ATP
- ATP + D-glucose –(hexokinase)–> ADP + G6P
- G6P + NADP+ –(G6PD)–> 6-PG + NADPH + H+
7
Q
Why might the three isoenzymes be separated by electrophoresis?
A
- CK is a protein made from two subunits or monomers - dimer
- the two monomers are coded for by two different genes
- these generate two different monomer isoforms - ‘B’ and ‘M’
- the two monomers have approximately the same molecular weight but differ in their isoelectric point (pl) = can be separated by charge
8
Q
How might one establish a diagnosis of myocardial damage?
A
- if both genes are expressed in a cell, three final dimers are possible - BB, MM, MB
- the brain only expresses the B gene = only makes B monomer so only BB form generated
- conversely the MM form is only one made in skeletal muscle cells - useful for diagnosing extent of skeletal muscle damage in MD
- the only tissue where both genes are expressed is cardiac muscle cells = make all three dimers, including the hybrid MB form
- thus, death of cardiac muscle fibres can be determined if the MB isoform of CK can be detected in serum
9
Q
Does an increase in serum CK activity relate to the size of the myocardial damage?
A
- levels of CK-MB in serum are directly proportional to the amount of cell death in the heart
- this is because each myocyte can be considered to be approximately of equal volume (equal likelihood of dying independently of their size)
- so, as each cell dies it releases a ‘quantum’ of CK into the extracellular fluid and thence into serum
10
Q
What is the time course of serum CK after a myocardial infarction?
A
- CK - increases steeply and peaks 24 hours after, then decreases
- SGOT - increases and peaks 48 hours after, then decreases (slightly shallower decrease)
- LDH - increases shallowly, peaks around 5 days after, then decreases shallowly
11
Q
What other markers can be used for diagnosis of myocardial damage?
A
- SGOT - serum glutamate oxaloacetate transaminase
- LDH - lactate dehydrogenase
- cardiac troponin - cardiac troponin I and troponin T only present in the heart - appearance in the serum is a specific marker for cardiac infarction (typically appearing in the serum 48h after infarction and persisting for approximately 5 days)